Finance

Lists
EHC:NYSE
Encompass Health Corp
120,97 US$
+0,98%
(+1,17) 1D
120,97 US$
0,00% (0,00)
After hours
Closed: 5 ოქტ, 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHC...
Open
119,71 US$
High
122,66 US$
Low
118,97 US$
Mkt. cap
11,93 მლრდ.
Avg. vol.
875,01 ათ.
Volume
1,06 მლნ.
Dividend
0,69%
Quarterly dividend
0,21 US$
Ex-dividend date
1 ოქტ. 2026
P/E ratio
19,74
52-wk high
127,99 US$
52-wk low
92,77 US$
EPS
6,13 US$
Beta
0,75
Shares outstanding
98,65 მლნ.
No. of employees
30 ათ.
Open
119,71 US$
High
122,66 US$
Low
118,97 US$
Mkt. cap
11,93 მლრდ.
Avg. vol.
875,01 ათ.
Volume
1,06 მლნ.
Dividend
0,69%
Quarterly dividend
0,21 US$
Ex-dividend date
1 ოქტ. 2026
P/E ratio
19,74
52-wk high
127,99 US$
52-wk low
92,77 US$
EPS
6,13 US$
Beta
0,75
Shares outstanding
98,65 მლნ.
No. of employees
30 ათ.
News stories
From web sources and news partners
Profile
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022. From 1996 to 2003, executives at the company committed accounting fraud on a large scale, leading to a scandal and financial restructuring. Wikipedia
About Encompass Health Corp
CEOმარკ ჯეი ტარ
Employees29,7 ათ.
Founded22 თებ. 1984
Headquartersბირმინგემი, ალაბამა, ამერიკის შეერთებული შტატები
SectorHealth care provider
Websiteencompasshealth.com
Analyst ratings
Based on 10 analysts giving stock ratings to EHC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EHC in the last 3 months.
Highest
Current 120,97 US$
155,00 US$ (+28,13%)
Average
146,78 US$ (+21,34%)
Lowest
140,00 US$ (+15,73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
140,00 US$
+15,7%
10/02/2026
Andrew Cooper
Raymond James
Buy
Reiterated
150,00 US$
+24%
09/28/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
142,00 US$
+17,4%
09/18/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
147,00 US$
+21,5%
09/17/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
140,00 US$
+15,7%
08/11/2026
David S Macdonald
Truist Financial
Buy
Maintained
150,00 US$
+24%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
150,00 US$
+24%
08/07/2026
A.J. Rice
UBS
Buy
Reiterated
155,00 US$
+28,1%
08/07/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
153,00 US$
+26,5%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
144,00 US$
+19%
08/06/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Reiterated
140,00 US$
+15,7%
05/04/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
150,00 US$
+24%
05/01/2026
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
1,55 US$ / 1,48 US$
+4,75%beat
Revenue / Est. (USD)
1,60 მლრდ. / 1,57 მლრდ.
+1,66%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,48 მლრდ.
1,54 მლრდ.
1,59 მლრდ.
1,60 მლრდ.
Cost of goods sold
849,40 მლნ.
865,60 მლნ.
882,40 მლნ.
886,40 მლნ.
Cost of revenue
849,40 მლნ.
865,60 მლნ.
882,40 მლნ.
886,40 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,00 მლნ.
88,20 მლნ.
73,40 მლნ.
77,30 მლნ.
Operating expense
384,50 მლნ.
395,60 მლნ.
402,60 მლნ.
422,60 მლნ.
Total operating expenses
1,23 მლრდ.
1,26 მლრდ.
1,28 მლრდ.
1,31 მლრდ.
Operating income
243,60 მლნ.
283,40 მლნ.
301,60 მლნ.
288,40 მლნ.
Other non operating income
5,90 მლნ.
3,70 მლნ.
1,20 მლნ.
9,10 მლნ.
EBT including unusual items
219,90 მლნ.
257,70 მლნ.
288,70 მლნ.
261,60 მლნ.
EBT excluding unusual items
219,90 მლნ.
257,70 მლნ.
271,40 მლნ.
264,80 მლნ.
Income tax expense
44,90 მლნ.
55,40 მლნ.
56,40 მლნ.
53,60 მლნ.
Effective tax rate
20,42%
21,50%
19,54%
20,49%
Other operating expenses
231,10 მლნ.
221,00 მლნ.
241,90 მლნ.
254,90 მლნ.
Net income
126,50 მლნ.
146,10 მლნ.
194,50 მლნ.
153,90 მლნ.
Net profit margin
8,56%
9,46%
12,26%
9,63%
Earnings per share
1,23
1,46
1,60
1,55
Interest and investment income
-
-
-
-
Interest expense
-30,80 მლნ.
-30,20 მლნ.
-31,80 მლნ.
-32,80 მლნ.
Net interest expenses
-30,80 მლნ.
-30,20 მლნ.
-31,80 მლნ.
-32,80 მლნ.
Depreciation and amortization charges
82,40 მლნ.
86,40 მლნ.
87,30 მლნ.
90,40 მლნ.
EBITDA
326,00 მლნ.
369,80 მლნ.
388,90 მლნ.
378,80 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები